Loading today’s stories

Today

AI-assisted reporting, grounded in a per-article claim ledger. Perspective Coverage and Reality Strip separate source viewpoints from evidence, adoption, hype, incentives, and confidence.

Today

Front Page
Today’s Briefing
Newsletters
Trending
For You
Discover
My Stack
Saved
Off Radar
Search

Sections

Security
Build
Invest
Product
Leadership
Science

Company

About
Mission
How this is made
Evidence Index
The desks
The sources we read
Corrections
Press and brand
The daily edition

Trending now

Apple Silicon
Agentic AI Security
AI lab unit economics
AI Copyright Litigation
Human-in-the-Loop Governance
AI-assisted vulnerability research
LLM Evaluation Methodology
On-device AI inference
AI-Generated Code Security
On-Chain Market Structure

How this is made

Today For You My Stack Off Radar Search

American Society for Reproductive Medicine — other — Clarity Today

other

American Society for Reproductive Medicine

Professional society whose recurrent pregnancy loss recommendations were updated earlier this year for the first time since 2012, adding conditional sperm DNA fragmentation testing.

Known aliases

ASRM

Relationships

No evidence-backed relationships are recorded.

Current clusters

science1 distinct publisher

A decades-old sperm DNA test finally makes ASRM's list, at the back of the queue

The first update to recurrent pregnancy loss guidance since 2012 names sperm DNA fragmentation testing, then places it behind two other evaluations. The test itself is not new.

Publishers:scientificamerican.com

Reality

Evidence34
Adoption31
Hype gap+29
Incentives46

Confidence38